Dr. Ahmed Refae is a consultant in Clinical Oncology for adults, bringing over 30 years of experience to the field. He began his career as an associate professor at Ain Shams University before relocating to Saudi Arabia 17 years ago, where he has worked in various governmental and private hospitals.
Dr. Refae is deeply involved in research, participating in multicenter international randomized clinical trials and authoring numerous publications. He believes that the best learning comes through teaching, which is why he actively engages in the scientific community as a speaker and presenter at both national and international conferences.
His dedication extends beyond patient care, as he is committed to fostering education and advancing oncology research, making significant contributions to the field.
Areas of expertise.
Education and training.
- 01MD, Clinical Oncology, Ain Shams University, Cairo, Egypt (1996-2002)
- 02Master's Degree, Clinical Oncology, Ain Shams University, Cairo (1993-1996)
- 03Medical School, Ain Shams University, Cairo, Egypt (1985-1992)
Boards and fellowships.
- 01MOH KSA license to Practice, 2023
Selected publications.
- 01A phase II study of cisplatin as radiosensitizer during standard radiotherapy for high grade gliomas, followed by lomustine based chemotherapy. Abdel Karim k., Lotfy A., Refae A., Elhusseiny K., Soud K. The Egyptian Journal of Neurosurgery, Jun, 2006.
- 02Brain metastases in breast cancer patients; one week versus two weeks whole brain radiotherapy; prognostic factors assessment. Refae A., Sharaf OM., Awad M., Saoud K. The Egyptian Journal of Neurosurgery, Jan 2008.
- 03Gemcitabine with oxaliplatin(GEMOX)in metastatic carcinoma of unknown primary (CUP). Refae AA., Fouad IM., Abdel Karim KM., Farag AL., Elhusseiny KN. Kasr Al Aini Medical Journal , jun., 2007.
- 04Induction cisplatin and weekly paclitaxel followed by radiotherapy and concurrent weekly cisplatin in loco-regionally advanced nasopharyngeal carcinoma. Refae AA., El-Kady MS., Farag AL., El-Ghazaly HA., Abdel karim NN., Sharaf OM., Shehata M. Scientific Journal of al-Azhar Medical College girls.2007.
- 05One year low dose oral etoposide as maintenance therapy in patients With advanced ovarian carcinoma after clinical complete response to platinum and paclitaxel chemotherapy. El-husseiny K., Refae A., Farag AL., Elghazaly H., Alebeisy H Scientific Journal of al-Azhar Medical College girls. Jan 2008.